Dark Forest Capital Management LP Heron Therapeutics, Inc. Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$2.25 - $4.67 $4,524 - $9,391	2,011 New	2,011 $5,000
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $1,711 - $4,679	-744 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.63 - $9.94 $1,773 - $3,807	383 Added 106.09%	744 $4,000
Q4 2021 Feb 11, 2022	SELL	$8.35 - $12.6 $22,787 - $34,385	-2,729 Reduced 88.32%	361 $3,000
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $30,369 - $44,970	2,998 Added 3258.7%	3,090 $33,000
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $1,220 - $1,700	92 New	92 $1,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.